These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29527269)

  • 1. Outcomes of kidney transplantation in patients with hepatitis B virus infection: A systematic review and meta-analysis.
    Thongprayoon C; Kaewput W; Sharma K; Wijarnpreecha K; Leeaphorn N; Ungprasert P; Sakhuja A; Cabeza Rivera FH; Cheungpasitporn W
    World J Hepatol; 2018 Feb; 10(2):337-346. PubMed ID: 29527269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and Prognostic Importance of Atrial Fibrillation in Kidney Transplant Recipients: A Meta-Analysis.
    Thongprayoon C; Chokesuwattanaskul R; Bathini T; Khoury NJ; Sharma K; Ungprasert P; Prasitlumkum N; Aeddula NR; Watthanasuntorn K; Salim SA; Kaewput W; Koller FL; Cheungpasitporn W
    J Clin Med; 2018 Oct; 7(10):. PubMed ID: 30347721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation and atrial fibrillation: A meta-analysis.
    Chokesuwattanaskul R; Thongprayoon C; Bathini T; Ungprasert P; Sharma K; Wijarnpreecha K; Pachariyanon P; Cheungpasitporn W
    World J Hepatol; 2018 Oct; 10(10):761-771. PubMed ID: 30386469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Kidney Transplant Patients with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab: A Systematic Review and Meta-Analysis.
    Gonzalez Suarez ML; Thongprayoon C; Mao MA; Leeaphorn N; Bathini T; Cheungpasitporn W
    J Clin Med; 2019 Jun; 8(7):. PubMed ID: 31252541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors and adverse effects in kidney transplant recipients: A meta-analysis.
    Boonpheng B; Thongprayoon C; Bathini T; Sharma K; Mao MA; Cheungpasitporn W
    World J Transplant; 2019 Jun; 9(2):35-47. PubMed ID: 31363460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outcomes of kidney transplantation in hepatitis B surface antigen (HBsAg)-negative recipients receiving graft from HBsAg-positive donors: a retrospective, propensity score-matched study.
    Chancharoenthana W; Townamchai N; Pongpirul K; Kittiskulnam P; Leelahavanichkul A; Avihingsanon Y; Suankratay C; Wattanatorn S; Kittikowit W; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Am J Transplant; 2014 Dec; 14(12):2814-20. PubMed ID: 25395260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and Mortality of Renal Cell Carcinoma after Kidney Transplantation: A Meta-Analysis.
    Chewcharat A; Thongprayoon C; Bathini T; Aeddula NR; Boonpheng B; Kaewput W; Watthanasuntorn K; Lertjitbanjong P; Sharma K; Torres-Ortiz A; Leeaphorn N; Mao MA; Khoury NJ; Cheungpasitporn W
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30999706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of parvovirus B19 and anemia among kidney transplant recipients: A meta-analysis.
    Thongprayoon C; Khoury NJ; Bathini T; Aeddula NR; Boonpheng B; Lertjitbanjong P; Watthanasuntorn K; Leeaphorn N; Chesdachai S; Torres-Ortiz A; Kaewput W; Bruminhent J; Mao MA; Cheungpasitporn W
    Urol Ann; 2020; 12(3):241-247. PubMed ID: 33100749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Kidney Transplantation in Fabry Disease: A Meta-Analysis.
    Suarez MLG; Thongprayoon C; Hansrivijit P; Medaura J; Vaitla P; Mao MA; Bathini T; Boonpheng B; Kanduri SR; Kovvuru K; Basu A; Cheungpasitporn W
    Diseases; 2020 Dec; 9(1):. PubMed ID: 33374610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients.
    Chan TM; Fang GX; Tang CS; Cheng IK; Lai KN; Ho SK
    Hepatology; 2002 Nov; 36(5):1246-52. PubMed ID: 12395336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients.
    Kim JM; Park H; Jang HR; Park JB; Kwon CH; Huh W; Lee JH; Kim SJ; Joh JW
    Ann Surg Treat Res; 2014 May; 86(5):256-63. PubMed ID: 24851227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease.
    Madayag RM; Johnson LB; Bartlett ST; Schweitzer EJ; Constantine NT; McCarter RJ; Kuo PC; Keay S; Oldach DW
    Transplantation; 1997 Dec; 64(12):1781-6. PubMed ID: 9422420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of cannabis use and associated outcomes among kidney transplant recipients: A meta-analysis.
    Vaitla PK; Thongprayoon C; Hansrivijit P; Kanduri SR; Kovvuru K; Rivera FHC; Cato LD; Garla V; Watthanasuntorn K; Wijarnpreecha K; Chewcharat A; Aeddula NR; Bathini T; Koller FL; Matemavi P; Cheungpasitporn W
    J Evid Based Med; 2021 May; 14(2):90-96. PubMed ID: 32558277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney Transplantation From Hepatitis B Surface Antigen (HBsAg)-Positive Living Donors to HBsAg-Negative Recipients: Clinical Outcomes at a High-Volume Center in China.
    Wang XD; Liu JP; Song TR; Huang ZL; Fan Y; Shi YY; Chen LY; Lv YH; Xu ZL; Li XH; Wang L; Lin T
    Clin Infect Dis; 2021 Mar; 72(6):1016-1023. PubMed ID: 32100025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients.
    Wang XD; Feng SJ; Liu JP; Song TR; Huang ZL; Fan Y; Shi YY; Chen LY; Lv YH; Xu ZL; Li XH; Wang L; Lin T
    BMC Infect Dis; 2021 Jan; 21(1):41. PubMed ID: 33422017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studies.
    Fabrizi F; Martin P; Dixit V; Kanwal F; Dulai G
    Am J Transplant; 2005 Dec; 5(12):2913-21. PubMed ID: 16303005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of viral hepatitis in solid organ transplantation].
    Mikolašević I; Sladoje-Martinović B; Orlić L; Milić S; Lukenda V; Župan Ž; Štimac D; Rački S
    Acta Med Croatica; 2014 Apr; 68(2):151-9. PubMed ID: 26012153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(-) donors.
    Yilmaz VT; Aliosmanoglu I; Erbis H; Ulger BV; Cetinkaya R; Suleymanlar G; Kocak H
    Transpl Infect Dis; 2016 Feb; 18(1):55-62. PubMed ID: 26565663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.